Details for 2016759295

Up to date per 02.04.2026

Actions

Title / Product Name

MIFEPRISTON UND OCTREOTID ZUR VERWENDUNG BEI DER BEHANDLUNG DES CUSHING-SYNDROMS BEI EINEM PATIENTEN MIT EINEM ADRENOCORTICOTROPEN HORMON (ACTH) SEZERNIERENDEN PANKREATISCHEN NEUROENDOKRINEN TUMOR

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016759295

EP Publication Number

3265127

E-Number

1658520

Language

PCT Number

US16019646

Publication Date

10.01.2018 A

21.02.2024 B1

Registration Date

21.02.2024

AT Publication Date

15.03.2024

Application Date

25.02.2016

Registration Number

Priorities

02.03.2015

201562127153 P

IPC

A61K 45/06 20060101AFI20180706BHEP

Maximum Duration of Protection

25.02.2036

Owner

Corcept Therapeutics, Inc.149 Commonwealth Drive Menlo Park CA 94025US

Representative

No representatives present

Inventor

MORAITIS, Andreas G.149 Commonwealth Drive Menlo Park, California 94025US

BELANOFF, Joseph K.149 Commonwealth Drive Menlo Park, California 94025US